UNC-Chapel Hill researchers have developed a therapeutic approach that harnesses helical amyloid fibers designed to untwist and release drugs in response to body temperature, according to a study published in Nature Communications. “Understanding the structural and assembly properties of the beta-amyloid 42 peptide is crucial for advancing our knowledge of Alzheimer’s and developing targeted therapies for… Continue reading Targeted therapy treatments – with a twist!